Access

Article


Nature Medicine 10, 966 - 973 (2004)
Published online: 22 August 2004 | doi:10.1038/nm1099

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm

Lei Zhao1, Michael P W Moos2, Rolf Gräbner2, Frédérique Pédrono1,3, Jinjin Fan1, Brigitte Kaiser2, Nicole John2, Sandra Schmidt2, Rainer Spanbroek2, Katharina Lötzer2, Li Huang4, Jisong Cui4, Daniel J Rader1,5, Jilly F Evans4, Andreas J R Habenicht2 & Colin D Funk1,3,5,6


Activation of the 5-lipoxygenase (5-LO) pathway leads to the biosynthesis of proinflammatory leukotriene lipid mediators. Genetic studies have associated 5-LO and its accessory protein, 5-LO-activating protein, with cardiovascular disease, myocardial infarction and stroke. Here we show that 5-LO-positive macrophages localize to the adventitia of diseased mouse and human arteries in areas of neoangiogenesis and that these cells constitute a main component of aortic aneurysms induced by an atherogenic diet containing cholate in mice deficient in apolipoprotein E. 5-LO deficiency markedly attenuates the formation of these aneurysms and is associated with reduced matrix metalloproteinase-2 activity and diminished plasma macrophage inflammatory protein-1alpha (MIP-1alpha; also called CCL3), but only minimally affects the formation of lipid-rich lesions. The leukotriene LTD4 strongly stimulates expression of MIP-1alpha in macrophages and MIP-2 (also called CXCL2) in endothelial cells. These data link the 5-LO pathway to hyperlipidemia-dependent inflammation of the arterial wall and to pathogenesis of aortic aneurysms through a potential chemokine intermediary route.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Aneurysms: leukotrienes weaken aorta from the outside

Nature Medicine News and Views (01 Sep 2004)

'Good' lipids for asthma

Nature Medicine News and Views (01 Sep 2002)

See all 3 matches for News And Views